كندا - الإنجليزية - Health Canada

teva canada limited - methotrexate (methotrexate sodium) - tablet - 2.5mg - methotrexate (methotrexate sodium) 2.5mg - antineoplastic agents

كندا - الإنجليزية - Health Canada

sandoz canada incorporated - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - methotrexate sodium - solution for injection - 25mg/1ml

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - methotrexate sodium - solution for injection - 25mg/1ml

كندا - الإنجليزية - Health Canada

pharmascience inc - methotrexate (methotrexate disodium) - tablet - 2.5mg - methotrexate (methotrexate disodium) 2.5mg - antineoplastic agents

كندا - الإنجليزية - Health Canada

mantra pharma inc - methotrexate (methotrexate disodium) - tablet - 2.5mg - methotrexate (methotrexate disodium) 2.5mg

كندا - الإنجليزية - Health Canada

pfizer canada ulc - methotrexate - tablet - 10mg - methotrexate 10mg - antineoplastic agents

كندا - الإنجليزية - Health Canada

apotex inc - methotrexate (methotrexate sodium) - tablet - 2.5mg - methotrexate (methotrexate sodium) 2.5mg - antineoplastic agents

كندا - الإنجليزية - Health Canada

strides pharma canada inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

teva parenteral medicines, inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. in acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is also indicated in the treatment of meningeal leukemia. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin's lymphomas. methotrexate in high doses followed by leucovorin rescue in combination with other chemotherapeutic agents is effective in prolonging relapse-free survival in patients with non-metastatic osteosarcoma who have undergone surgical resection